American Century Companies’s ChemoCentryx, Inc. CCXI Stock Holding History

American Century Companies’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-181,365	Closed	-$9.29M	–	2366
2021 Q1	$9.29M	Buy	181,365 +15,709	+9%	+$945K	0.01%	792
2020 Q4	$10.3M	Sell	165,656 -3,300	-2%	-$189K	0.01%	760
2020 Q3	$9.26M	Buy	168,956 +24,920	+17%	+$1.34M	0.01%	726
2020 Q2	$8.29M	Buy	144,036 +26,493	+23%	+$1.44M	0.01%	717
2020 Q1	$4.72M	Buy	117,543 +2,445	+2%	+$104K	0.01%	734
2019 Q4	$4.55M	Buy	+115,098	New	+$2.02M	﹤0.01%	817
2019 Q1	–	Sell	-65,787	Closed	-$718K	–	1348
2018 Q4	$718K	Sell	65,787 -103,250	-61%	-$1.09M	﹤0.01%	1086
2018 Q3	$2.14M	Buy	169,037 +5,166	+3%	+$62.2K	﹤0.01%	1016
2018 Q2	$2.16M	Buy	163,871 +132,592	+424%	+$1.59M	﹤0.01%	1010
2018 Q1	$425K	Buy	+31,279	New	+$323K	﹤0.01%	1175
2017 Q4	–	Sell	-35,991	Closed	-$267K	–	1395
2017 Q3	$267K	Sell	35,991 -5,451	-13%	-$45.3K	﹤0.01%	1283
2017 Q2	$388K	Buy	41,442 +698	+2%	+$5.12K	﹤0.01%	1260
2017 Q1	$297K	Buy	+40,744	New	+$293K	﹤0.01%	1280

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies's CCXI Position: Q2 2021 in Review

American Century Companies sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 181,365 shares — an estimated $9.29M sold.

American Century Companies first reported a position in CCXI in Q1 2017 and held it in 13 quarters. The position peaked at $10.3M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

American Century Companies reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
American Century Companies sold 181,365 ChemoCentryx, Inc. shares in Q2 2021, an estimated $9.29M.
American Century Companies first reported a position in ChemoCentryx, Inc. in Q1 2017 and held it in 13 quarters.
American Century Companies's ChemoCentryx, Inc. position peaked at $10.3M in Q4 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on American Century Companies's 13F filing for Q2 2021, filed 5 Aug 2021.